DCB for CAD With Type 2 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

July 1, 2028

Conditions
Coronary Artery DiseaseDiabete Type 2
Interventions
DEVICE

Drug-Coated Balloon (DCB)

Following lesion preparation (usually with a standard balloon), a drug-coated balloon is advanced to the target lesion. The balloon is inflated and maintained to allow effective drug transfer to the vessel wall.

DEVICE

Drug-Eluting Stent (DES) implantation

After coronary angiography identifies the target lesion, a DES is selected based on the vessel size. Post-deployment angiography is performed to confirm the result and check for complications.

Trial Locations (6)

200072

Shanghai Tenth People's Hospital, Shanghai

Unknown

Huaihe Hospital of Henan University, Kaifeng

Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang

The First Affiliated Hospital of Zhengzhou Uninversity, Zhengzhou

The Second People's Hospital of Yibin, Yibin

Ninghai First Hospital, Ningbo

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER